Member Info for Lp160606

Well, yes i would hope. But i remember June and i was expecting contracts to follow CE Mark.

come on, the RNS wasn't that good.

They took advantage of a loophole they should bloody used 4 months ago! And no clear sales update.

It is progress, yes. But not the right progress. I'd expect sales to follow but i wouldn't be surprised if it is radio silence until Jan now.

Anyone with half a brain knows that thinking is flawed. but you know, rampers they ramp.

This genuinely comes down to do you trust David Budd to close a double/triple digit testing contract with Beckman? And if that is a yes, ask why that has not already happened as we are so closely aligned.

Looking at the charts gives a skewed view though.

NCYT had already achieved sales, and had a number of approvals before drifting back. Equally a very competent Bod, and a 30+ sales teams.

You really trust David Budd to land a 50M deal + ? That's the only way this goes back to anywhere near £2.

Correct. 0 material sales in any country they are cleared to sell into.

And they have just taken advantage of a loophole here that existed 4 months ago.

BarnetPeter,

It slipped my mind that the new shares hit the market today.. telling.

They've earmarked Q1 for PoC test so probably get released in March.

True.

How did he know as even i was convinced..

lol Dave you are on a wind up, right?

Been saying this week since July.

LTH you attempted to belittle me. Do not speak to someone in the tone you did and not expect the exact level of respect returned and then get upset.

You wrote what you did in an attempt to discredit my points without actually addressing them. As what many here do, because they can not counter what i say because either they know it to be true and do not want to hear it, or haven't done enough research to do so.

Ok so they had spent 1M out of the 9M.. i was slightly off with my %.

Still begs the question does it not? What was the hold up if the money was needed so urgently.. They like every other bio secured their future and have delivered 0 value to shareholders since.

You would think not wouldn't you. Would appear particular amatuerish wouldn't it.

The 9M they never really spent?

To supplement initial demand & set up the supply chain (LTH is so well versed in or so he likes to claim).

odd that 90% of it was still in company coffers at the half year results wasn't it...

lol LTH, i know more about this rabbles failings then i care to write, and it will come out at some point.

I know they failed ICMR because i did my due diligence and picked the phone up to the site in Delhi. You can do the same, but you won't because you believe everything GDR tell you and is why i left this business on a very small gain and you are sat here 40% down.

But i'll humour you LTH. Lets address Beckman & the FDA

We were able to achieve what we have today 4 months ago when the FDA changed their approval specs, allowing LDTs to bypass the regulations.
We then engaged with beckman in order to achieve internal validation but they wanted saliva as next gen. But we failed Saliva validation (no mention in the new update on progress there, funny right?)
Beckman set up a lab for GDr but stated FDA was required. Again strange considering todays announcement isn't it.. But no mention of this site going live?

Oh and those sales in Europe... yeh the ****ing morons let slip they were from charging companies for the 70,000 samples they sent out.

That is how useless these lot are.

Bitter?

Most people who hold a position here will still be between 40-60% down. Many probably wanted to see FDA approval but this is something the BoD could of done in September.. so why are they doing it now? And why are there no sales attached to it?

The are just a frustrating company as nothing is ever as it seems, they entire blurb is on the rising cases in the US and how they want to commercialise but nothing of clear merit where we will be doing a,b & c.

I am still yet to see anything that demonstrates they can commercialise.

Exactly Iphone.

I have emails from him stating this was possible back in August.. but that they were opting for authorization through Beckman.. well that again isn't something they've gone for?

Its good news, but it isn't approval.

Why no mention of this singular site they supposedly set up with Beckman?

Light on specifics as ever, not really sure there is any substance to this.. why no sales? surely that would be the driver to opt down this route.

The product will bear a labelling stating that "validation of this test has not been reviewed by FDA. Review under the EUA program is pending".

The only takeaway.

And all they have delivered is a test. Nothing else, 0 expansion & further dilution along the way.

Although i believe Covid revenues will run on all the way through 2021, have the BoD not already proven to you all they unable to execute on this particular opportunity?

Sent 70k samples to Europe & SA - 0 sales to show from it.
Ran placing to set up supply chains and supplement initial demand - nothing to show from it. have 90% of it in their cofffers 2 months later...
Applied for FCA & ICMR in June - 6 months ago. Given their admittance of radio silence from the ICMR for a few months it puts further weight behind my belief they failed ICMR.
David Budd has made 3/4 claims proven to be rubbish - sales in June/Global sales strategy/Distancing from UK gov initially/Beckman **** up with saliva.
Beckman opp has been proven to be a technical engagement when we were all led to believe it was the start of a global roll out.

Then DB claims approvals are 'very close' that is now i believe over a month ago.

They just haven't shown me anything to believe they can execute in relation to Covid. Anyone labelling someone as a troll for airing their grievances here is under no uncertain terms a f#cking moron.

Going to be a good day here.

Are you for real?

The only comparison is they are German. ffs.

can't sell a bean. Likely close mid 9s.